Who makes Dovitinib and docetaxel?

Dovitinib and docetaxel is developed by Asan Medical Center.

What development phase is Dovitinib and docetaxel in?

Dovitinib and docetaxel is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Dovitinib and docetaxel

Asan Medical Center · Phase 1 active Small molecule

At a glance

Generic name	Dovitinib and docetaxel
Sponsor	Asan Medical Center
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Dovitinib and docetaxel CI brief — competitive landscape report
Dovitinib and docetaxel updates RSS · CI watch RSS
Asan Medical Center portfolio CI